revive tirzepatide ✨ It's Never Too Late

Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool

Medical guidance you can trust.

IntroductionThe surge in prescribing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for diabetes and weight management highlights a pressing need to c...

See how they compare in purpose, cost, side effects, and weight-loss outcomes.

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease

Does Zepbound make you pee a lot